Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-09-12 00:00:00 ET · period of report 2023-09-12 · accession 0000950170-23-047712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-12 | 2023-09-12 | KPTI | BOHLIN GAREN G | Dir | P - Purchase | $1.22 | +41.1K | 45.1K | +1,028% | +$50.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-12 | P | A | 41,140 | $1.22 | 45,140 | D | — | — | (F1) Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.1935 to $1.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.. |